IMPLANT SITE DEHISCENCE

This adverse event was reported 86 times

These drugs are most commonly taken by patients reporting IMPLANT SITE DEHISCENCE:

# Drug Count
0 BACLOFEN 16
1 BACLOFEN INJECTION 14
2 ETONOGESTREL 8
3 BEVACIZUMAB 7
4 ACETAMINOPHEN 6
5 FLUOROURACIL 5
6 FLUOROURACIL CREAM, 0.5% 5
7 OXALIPLATIN 5
8 BUPIVACAINE 4
9 BUPIVACAINE HYDROCHLORIDE IN DEXTROSE 4
See all common drugs associated with IMPLANT SITE DEHISCENCE

IMPLANT SITE DEHISCENCE is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 BACLOFEN INJECTION 14 0.0045
1 METHYLNALTREXONE BROMIDE 2 0.0013
2 BUPIVACAINE HYDROCHLORIDE IN DEXTROSE 4 0.0005
3 NALOXEGOL OXALATE 2 0.0005
4 BUPIVACAINE 4 0.0004
5 DEXTROMETHORPHAN HYDROBROMIDE AND QUINIDINE SULFATE 1 0.0003
6 DOBUTAMINE 1 0.0003
7 CHLORAMBUCIL 1 0.0003
8 PANITUMUMAB 4 0.0002
9 CEFAZOLIN SODIUM 3 0.0002
See all drugs enriched for association with IMPLANT SITE DEHISCENCE